InsidersTradesSigma
Track the Delta-Fly Pharma株式会社 stock price and the full insider trade history of the company, a publicly traded company based in Japan. Shares are listed on JP JP, under the oversight of EDINET (Japan FSA). Market capitalisation: €1.8bn. The latest transaction was filed on 26 January 2026 (Holding update). Among the most active insiders: SBI SECURITIES Co.,Ltd.. The full history is openly available.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
11 of 11 declarations
Delta-Fly Pharma is a pharmaceutical company listed on the XTKS market. It focuses on the development of innovative drugs and therapeutic solutions.